CJC-1295 (no DAC) vs CJC-1295 + Ipamorelin
Both CJC-1295 (no DAC) and CJC-1295 + Ipamorelin are kept in stock here and are frequently weighed against each other. This page lays out where they diverge: how each is classed, what sizes exist and the per-milligram price, the shape of the evidence published on each, and how Canadian law treats them. It draws no ranking between them, since which one fits turns on what is being studied.
Side by side
| CJC-1295 (no DAC) | CJC-1295 + Ipamorelin | |
|---|---|---|
| Class | Growth hormone-releasing hormone (GHRH) analogue | Two-peptide research blend: a GHRH analogue and a ghrelin receptor (GHS-R) agonist |
| Sizes and price | 10 mg — from $38.00 (best $3.80/mg) | 10 mg — from $69.00 (best $6.90/mg) |
| Published evidence | 6 cited studies; 1 controlled trial in people. | 8 cited studies; 2 controlled trials in people. |
| Models studied | rat, rat anterior pituitary membranes, in vitro structure-activity study of hgrf-nh2 analogues | human, rat pituitary cells in vitro, rat |
| Status in Canada | No Drug Identification Number; named in a Health Canada advisory | No Drug Identification Number; named in a Health Canada advisory |
| Formats | vial, starter | blend, starter, value |
Key differences
The evidence on record, CJC-1295 (no DAC): 6 cited studies; 1 controlled trial in people. And CJC-1295 + Ipamorelin: 8 cited studies; 2 controlled trials in people.
No published study has set CJC-1295 (no DAC) against CJC-1295 + Ipamorelin head to head. The figures above come from separate studies of each compound, so the two columns are not the output of a single experiment.
Both are provided strictly for in-vitro laboratory research, and neither is meant for human or veterinary use.
FAQ
How do CJC-1295 (no DAC) and CJC-1295 + Ipamorelin differ?
CJC-1295 (no DAC) is growth hormone-releasing hormone (ghrh) analogue, whereas CJC-1295 + Ipamorelin is two-peptide research blend: a ghrh analogue and a ghrelin receptor (ghs-r) agonist. The table above breaks down each size, the per-milligram price, the evidence behind each compound and where each stands in Canada.
Which of CJC-1295 (no DAC) and CJC-1295 + Ipamorelin has more published research?
CJC-1295 (no DAC) lists 6 cited studies on its page and CJC-1295 + Ipamorelin lists 8. A higher count is not a mark of quality: the model behind each study counts for more, and both pages record that for every paper.
Are CJC-1295 (no DAC) and CJC-1295 + Ipamorelin authorized for sale in Canada?
For CJC-1295 (no DAC): No Drug Identification Number; named in a Health Canada advisory. For CJC-1295 + Ipamorelin: No Drug Identification Number; named in a Health Canada advisory. Health Canada authorizes a drug by assigning an eight-digit Drug Identification Number, and most research peptides hold none.
Can CJC-1295 (no DAC) and CJC-1295 + Ipamorelin be combined?
No published study has examined the two in combination, so there is no evidence on what pairing them does. We supply both for laboratory research and make no claim about using them together.